U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07570615) titled 'Development and Validation of a Chinese Quality of Life Scale for Pulmonary Arterial Hypertension' on April 30.
Brief Summary: This study aims to develop and validate a culturally appropriate, reliable, and clinically applicable patient-reported outcome (PRO) instrument to assess quality of life in patients with pulmonary arterial hypertension (PAH) in China.
The study includes two phases: (1) scale development using literature review, Delphi expert consultation, and patient interviews; and (2) multicenter prospective observational validation to evaluate reliability, validity, and responsiveness.
The final scale is expected to suppo...